Free Trial
NYSE:BWXT

BWX Technologies Q2 2025 Earnings Report

BWX Technologies logo
$142.89 +0.55 (+0.39%)
Closing price 03:59 PM Eastern
Extended Trading
$142.85 -0.04 (-0.03%)
As of 05:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BWX Technologies EPS Results

Actual EPS
N/A
Consensus EPS
$0.79
Beat/Miss
N/A
One Year Ago EPS
N/A

BWX Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
$708.00 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

BWX Technologies Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Monday, August 4, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

BWX Technologies Earnings Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
BWX Technologies (NYSE:BWXT) Raised to "Buy" at Wall Street Zen
See More BWX Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BWX Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BWX Technologies and other key companies, straight to your email.

About BWX Technologies

BWX Technologies (NYSE:BWXT) (NYSE: BWXT) is a global leader in nuclear components and fuel manufacturing, with roots tracing back to the Babcock & Wilcox Company’s nuclear operations founded in the mid-20th century. The company was established as an independent, publicly traded entity in 2015, when it spun off from its parent to focus exclusively on nuclear technologies and services. Over the decades, BWXT has evolved through strategic acquisitions and internal innovation to become a key technology partner for government and commercial customers around the world.

BWXT’s core business is organized into two operating segments: Naval Nuclear and Nuclear Operations Group. The Naval Nuclear segment designs, manufactures and overhauls naval nuclear propulsion systems, providing reactor cores, fuel and related components for the U.S. Navy’s aircraft carriers and submarines. This segment also offers long-term engineering and maintenance services to ensure fleet readiness and safety. The Nuclear Operations Group encompasses commercial nuclear fuel and reactor components, small modular reactor (SMR) development, and the production of medical isotopes for diagnostic and therapeutic applications.

In the commercial realm, BWXT manufactures uranium fuel assemblies for light water reactors, supplies Zircaloy cladding and advanced materials, and supports life-extension programs for existing nuclear power plants. The company’s SMR initiatives focus on the design and licensing of cost-effective reactors with enhanced safety features for industrial and utility markets. Additionally, BWXT is among the few U.S. producers of molybdenum-99, a critical isotope used in medical imaging, and it advances research into next-generation radioisotopes.

BWXT operates from manufacturing sites and research facilities across North America, Europe, the Middle East and Asia, serving a diverse global customer base. Under the leadership of President and CEO John J. MacPherson, the company emphasizes quality assurance, regulatory compliance and innovation in nuclear science. BWXT continues to pursue strategic partnerships and technology investments aimed at supporting clean energy initiatives, national security programs and the evolving needs of the nuclear industry.

View BWX Technologies Profile

More Earnings Resources from MarketBeat